Our results suggested that in the context of FOI treatment, compared with the vector group, the tumor was significantly enlarged after overexpression of GALNT5, while the tumor growth was significantly inhibited after continued knocking down MYH9. The gene discussed is GALNT5; the disease is neoplasm.